These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2701297)

  • 41. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions of the opioid and immune systems.
    Donahoe RM
    NIDA Res Monogr; 1989; 95():186-91. PubMed ID: 2701297
    [No Abstract]   [Full Text] [Related]  

  • 44. [Endogenous opiate neuropeptides and the immune system].
    Vasil'eva EV; Sukhikh GT; Vinogradov VA; Sura VV
    Ter Arkh; 1984; 56(10):120-5. PubMed ID: 6098041
    [No Abstract]   [Full Text] [Related]  

  • 45. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression?
    Ruppert J; Franco A; Alexander J; Snoke K; Ishioka GY; Page DM; Hedrick SM; Adorini L; Grey HM; Sette A
    Chem Immunol; 1995; 60():61-78. PubMed ID: 7857529
    [No Abstract]   [Full Text] [Related]  

  • 47. T cell tolerance.
    Vacchio MS; Ashwell JD
    Chem Immunol; 1994; 58():1-33. PubMed ID: 8011149
    [No Abstract]   [Full Text] [Related]  

  • 48. Revival of the regulatory T cell: new targets for drug development.
    Sutmuller RP; Offringa R; Melief CJ
    Drug Discov Today; 2004 Apr; 9(7):310-6. PubMed ID: 15037230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerance: facts and views--1984.
    Parks DE
    Year Immunol; 1985; ():86-92. PubMed ID: 3916383
    [No Abstract]   [Full Text] [Related]  

  • 50. The T-cell repertoire.
    Sharrock C
    Immunol Suppl; 1988; 1():47-9. PubMed ID: 3290101
    [No Abstract]   [Full Text] [Related]  

  • 51. The thymus and central tolerance.
    Sprent J; Kishimoto H
    Transplantation; 2001 Oct; 72(8 Suppl):S25-8. PubMed ID: 11888152
    [No Abstract]   [Full Text] [Related]  

  • 52. Granulocyte colony-stimulating factor for the induction of T-cell tolerance.
    Rutella S
    Transplantation; 2007 Jul; 84(1 Suppl):S26-30. PubMed ID: 17632408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
    Liston A; Enders A; Siggs OM
    Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune mechanism of drug hypersensitivity.
    Pichler WJ
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):373-97, v-vi. PubMed ID: 15242717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine action in blockade of cellular immune responses.
    Lorber MI
    Year Immunol; 1986; 2():279-88. PubMed ID: 3554824
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction of tolerance in mature peripheral T cells.
    Arnold B; Schönrich G; Hämmerling GJ
    Exp Nephrol; 1993; 1(2):72-7. PubMed ID: 8081959
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.